Skip to main content
ICMLF
  • Home
  • About us Toggle submenu
    • Overview
    • What we do
    • The challenge
    • Our impact
    • Our history
    • Our team
    • Contact us
  • News & Events Toggle submenu
    • News
    • Events
    • The iCMLf Prizes
  • Resources & Information Toggle submenu
    • Physicians & Scientists
    • Patients & Carers
  • Get Involved Toggle submenu
    • Make a donation
    • Partner with us
    • Expert support
    • Fundraise
    • Climb for a Cure
    • Give in honor
    • Sign up
Search Donate

Breadcrumb

  1. Home
  2. Resources and Information
  3. Physicians and Scientists
  4. Resource Hub
  5. Beyond ATP: Asciminib and The Allosteric Path In CML
Back to resource hub
  • Date: 25 March 2026
  • Author: External Resource
  • Resource Type: Journal Article
  • Topic: Tyrosine Kinase Inhibitors (TKIs)

Beyond ATP: asciminib and the allosteric path in CML

Blood , Mar 2026

Abruzzese E et al. Blood, March 2026

Link to full abstract
  • Share
  • Tweet
  • Share
  • Share
ICMLF Logo

The International CML Foundation (iCMLf) is on a mission to improve outcomes for patients with CML, globally. We are committed to ensuring every patient with CML, no matter where they are in the world, receives the best possible care, fostering international collaboration to elevate knowledge, enhance diagnostics, and drive ground-breaking research.

Contact us

International CML Foundation

20 Eversley Road

Bexhill On Sea

East Sussex

TN40 1HE

UK

info@cml-foundation.org 

The iCMLf is registered as charity no. 1132984 in England and Wales

Copyright © 2026 All Rights Reserved | Privacy policy | Cookie Policy